The pancreatic-endocrine-osseous axis involves a potential link between DPP-4, bone, and energy metabolism through the receptor activator of nuclear factor kappa B ligand (RANKL), which induces DPP-4 expression in osteoclasts, leading to decreased GLP-1 levels and increased blood glucose levels
Wan et al., Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
Advice is also available online at poisonhelp.org
Weight loss has been shown to result in improvements in many comorbidities associated with obesity and T2D
Petersen J, Ingemann JVB, Clemmensen C
Most of these peptides are promoted by social media influencers as purported to offer health and wellness benefits, from speeding up recovery after injury to slowing down the ageing process